Result of AGM

RNS Number : 0434A
Integumen PLC
24 September 2020
 

 

24 September 2020

 

 

AIM share code: SKIN

24 September 2020

 

Integumen PLC

 

("Integumen" or "Company")

 

Result of Annual General Meeting

 

Following today's Annual General Meeting ("AGM"), convened by the Notice of AGM dated 1 September 2020, Integumen plc (to be renamed DeepVerge plc) is pleased to announce that all resolutions set out in the Notice of AGM were approved by shareholders.

 

The results of the poll for each resolution were as follows:

 

Resolution

For

% For

Against

% Against

Withheld

1. To receive and adopt the report of the directors and the financial statements for the year ended 31 December 2019.

24,416,932

99.88%

4,444

0.02%

25,000

2. To re-appoint Jeffreys Henry LLP as auditors.

24,416,932

99.88%

4,444

0.02%

25,000

3. To determine the remuneration of the auditors.

24,416,932

99.88%

4,444

0.02%

25,000

4. To re-elect Ross Andrews as a director of the Company.

23,082,691

94.42%

1,338,685

5.48%

25,000

5. To authorise the directors to allot shares pursuant to Section 551 of the Companies Act 2006.

24,393,803

99.78%

27,574

0.11%

25,000

6. To authorise the directors to allot shares for cash pursuant to Section 571(1) of the Companies Act 2006.

24,379,570

99.73%

66,806

0.27%

-

 

As at the date of the AGM, the number of issued ordinary shares of the Company was 113,185,643 shares, which was the total number of shares entitling the holders to attend and vote for or against all resolutions. In accordance with the Company's Articles of Association, on a poll every member has one vote for every share held. Votes withheld are not votes in law and have not been counted in the calculation of the proportion of vote "for" or "against" a resolution. Proxy appointments which gave discretion to the Chairman have been included in the "for" total.

 

Following today's AGM result, a short video will be posted on the Company's website: https://www.integumen.com/investors/

 

 

For further information please visit http://www.integumen.com/ or contact:

 

Enquiries:

 

Integumen plc

Gerard Brandon, CEO

+44 (0) 7340 055 648




SPARK Advisory Partners Limited

(Nominated Adviser)

Neil Baldwin/Andrew Emmott

+44 (0) 113 370 8974




Turner Pope Investments (TPI) Limited

(Broker)

Andy Thacker

+44 (0) 20 3621 4120

 

 

About Integumen

 

Integumen is a scientific research and AI-as-a-Service company focused on production and analysis of bacteria, virus and toxins utilising artificial intelligent data analytics in regulatory technology, from scientifically proving the impact of skincare product claims on skin microbiome for top 10 global cosmetic company clients to remotely detecting water contamination in real-time.

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RAGBDGDCGGDDGGS
UK 100

Latest directors dealings